
Masimo Corporation
MASIMasimo Corporation (MASI) is a global healthcare technology company known for developing innovative non-invasive monitoring solutions. Founded in 1989, it specializes in pulse oximetry, patient monitoring, and anesthesia delivery systems, aiming to improve patient outcomes through advanced sensing and data analysis technologies.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 11, 2012 | $1.00 | 2012-11-23 | 2012-11-27 |
| December 21, 2010 | $0.75 | 2010-12-03 | 2010-12-07 |
| March 31, 2010 | $2.00 | 2010-03-09 | 2010-03-11 |
Dividends Summary
- Consistent Payer: Masimo Corporation has rewarded shareholders with 3 dividend payments over the past 2 years.
- Total Returned Value: Investors who held MASI shares during this period received a total of $3.75 per share in dividend income.
- Latest Payout: The most recent dividend of $1.00/share was paid 4791 days ago, on December 11, 2012.
- Dividend Growth: Since 2010, the dividend payout has decreased by 50.0%, from $2.00 to $1.00.
Company News
The global Medical Device Connectivity Market is projected to grow at a CAGR of 23.40% from 2026 to 2032, expanding from USD 2.49 Billion in 2024 to USD 13.4 Billion by 2032. Growth is driven by increasing demand for IoT-enabled healthcare systems, remote patient monitoring, and favorable regulatory frameworks, though high implementation costs an...
The global pulse oximeter market is valued at USD 3.8 billion in 2025 and is expected to grow to USD 6.76 billion by 2034 at a 6.64% CAGR. North America currently dominates the market, while Asia-Pacific is experiencing rapid growth. Key drivers include rising chronic respiratory diseases, remote patient monitoring advancements, and wearable tech...
Masimo outlined its long-term strategy at the 2025 Investor Day, projecting 7-10% revenue growth and 30% operating margins by 2028. The company aims for $8.00 adjusted EPS and expects to generate $1 billion in operating cash flow from 2026-2028.
Apple experienced significant developments including a record-breaking streaming drama, launching an iPhone Pocket accessory, strengthening sales in China, and being ordered to pay $634 million in a patent infringement case.
The global neonatal infant care market is projected to grow from $3.63 billion in 2025 to $6.70 billion by 2034, driven by rising preterm birth rates and advanced NICU technologies. North America leads the market, while Asia Pacific shows the fastest growth.

